Convalescent plasma for patients with multiple myeloma and COVID-19; the European Myeloma Network consensus.

Terpos, Evangelos; Musto, Pellegrino; Engelhardt, Monika; Ntanasis-Stathopoulos, Ioannis; Sonneveld, Pieter; Ludwig, Heinz

Terpos, Evangelos; Musto, Pellegrino; Engelhardt, Monika; Ntanasis-Stathopoulos, Ioannis; Sonneveld, Pieter; Ludwig, Heinz.

Afiliación

Terpos E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. eterpos@med.uoa.gr.
Musto P; Department of Precision and Regenerative Medicine and Ionian Area, "Aldo Moro" University School of Medicine, Bari, Italy.
Engelhardt M; Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico, Bari, Italy.
Ntanasis-Stathopoulos I; Department of Hematology and Oncology, Interdisciplinary Cancer Center and Comprehensive Cancer Center Freiburg, University of Freiburg, Faculty of Freiburg, Freiburg, Germany.
Sonneveld P; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Ludwig H; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

Leukemia ; 37(9): 1939-1940, 2023 09.

Article en En | MEDLINE | ID: mdl-37507424

Asunto(s)

COVID-19; Mieloma Múltiple; Humanos; Mieloma Múltiple/terapia; Consenso; Sueroterapia para COVID-19; SARS-CoV-2

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 / Mieloma Múltiple Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Grecia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google